Everolimus in Treating Patients WIth Recurrent or Metastatic Breast Cancer

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2005
RATIONALE: Everolimus may stop the growth of tumor cells by blocking blood flow to the tumor. PURPOSE: This randomized phase II trial is studying two different schedules of everolimus to see how well they work in treating patients with recurrent or metastatic breast cancer.
Epistemonikos ID: 1e35d5590966721f3bf71d3814e19116ca64b255
First added on: May 04, 2024